PL4077639T3 - Sposób wytwarzania komórek immunoregulatorowych w próbce pochodzącej z krwi - Google Patents

Sposób wytwarzania komórek immunoregulatorowych w próbce pochodzącej z krwi

Info

Publication number
PL4077639T3
PL4077639T3 PL20833822.8T PL20833822T PL4077639T3 PL 4077639 T3 PL4077639 T3 PL 4077639T3 PL 20833822 T PL20833822 T PL 20833822T PL 4077639 T3 PL4077639 T3 PL 4077639T3
Authority
PL
Poland
Prior art keywords
immunoregulator
blood
cells
producing
derived sample
Prior art date
Application number
PL20833822.8T
Other languages
English (en)
Inventor
Robert ZEISER
Petya Apostolova
Justus Duyster
Original Assignee
Mallinckrodt Pharmaceuticals Ireland Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Pharmaceuticals Ireland Limited filed Critical Mallinckrodt Pharmaceuticals Ireland Limited
Publication of PL4077639T3 publication Critical patent/PL4077639T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0066—Psoralene-activated UV-A photochemotherapy (PUVA-therapy), e.g. for treatment of psoriasis or eczema, extracorporeal photopheresis with psoralens or fucocoumarins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0646—Natural killers cells [NK], NKT cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/15—Natural-killer [NK] cells; Natural-killer T [NKT] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2529/00—Culture process characterised by the use of electromagnetic stimulation
    • C12N2529/10—Stimulation by light

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL20833822.8T 2019-12-20 2020-12-17 Sposób wytwarzania komórek immunoregulatorowych w próbce pochodzącej z krwi PL4077639T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19218724 2019-12-20
PCT/EP2020/086733 WO2021122969A1 (en) 2019-12-20 2020-12-17 Method for generating immunoregulatory cells in a blood-derived sample

Publications (1)

Publication Number Publication Date
PL4077639T3 true PL4077639T3 (pl) 2024-09-30

Family

ID=69005255

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20833822.8T PL4077639T3 (pl) 2019-12-20 2020-12-17 Sposób wytwarzania komórek immunoregulatorowych w próbce pochodzącej z krwi

Country Status (16)

Country Link
US (2) US12491248B2 (pl)
EP (2) EP4374876A3 (pl)
JP (2) JP7701925B2 (pl)
KR (1) KR20220118404A (pl)
CN (1) CN114901809A (pl)
AU (1) AU2020404121A1 (pl)
BR (1) BR112022010129A2 (pl)
CA (1) CA3164882A1 (pl)
DK (1) DK4077639T3 (pl)
ES (1) ES2985816T3 (pl)
FI (1) FI4077639T3 (pl)
IL (1) IL293773A (pl)
MX (1) MX2022006381A (pl)
PL (1) PL4077639T3 (pl)
PT (1) PT4077639T (pl)
WO (1) WO2021122969A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115735846B (zh) * 2022-11-29 2025-09-16 复旦大学附属华山医院 磁场联合光化学诱导无创性缺血性脑卒中模型的建立方法
CN120641093A (zh) * 2022-12-21 2025-09-12 马林克罗特制药爱尔兰有限公司 脂联素单独或与体外光分离置换(ecp)组合用于治疗免疫检查点抑制剂的免疫相关不良事件
EP4389122A1 (en) * 2022-12-21 2024-06-26 Mallinckrodt Pharmaceuticals Ireland Limited Adiponectin alone or in combination with extracorporeal photopheresis (ecp) for immune related adverse events of immune checkpoint inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126366A (en) 1996-03-29 2011-10-31 Therakos Inc Use of a photoactivatable compound in the manufacture of a medicament for the treatment of an infection
JP4166432B2 (ja) * 1997-07-10 2008-10-15 セラコス・インコーポレイテッド 腸又は膀胱の炎症性疾病の処置
TWI324068B (en) * 2003-03-13 2010-05-01 Kirin Holdings Kk Antiallergic composition
EP2443922B1 (en) * 2005-11-02 2017-05-03 Therakos, Inc. The use of apoptotic cells ex vivo to generate regulatory T cells
CN108578675A (zh) * 2018-03-13 2018-09-28 中国农业大学 一种小鼠嗜酸性粒细胞食管炎食物过敏模型的建立方法

Also Published As

Publication number Publication date
EP4077639A1 (en) 2022-10-26
DK4077639T3 (da) 2024-08-19
EP4077639B1 (en) 2024-06-12
WO2021122969A1 (en) 2021-06-24
JP7701925B2 (ja) 2025-07-02
EP4374876A3 (en) 2024-08-07
CN114901809A (zh) 2022-08-12
EP4374876A2 (en) 2024-05-29
BR112022010129A2 (pt) 2022-08-09
ES2985816T3 (es) 2024-11-07
CA3164882A1 (en) 2021-06-24
IL293773A (en) 2022-08-01
AU2020404121A1 (en) 2022-06-23
JP2025126235A (ja) 2025-08-28
PT4077639T (pt) 2024-09-10
MX2022006381A (es) 2022-06-24
US20230024405A1 (en) 2023-01-26
KR20220118404A (ko) 2022-08-25
FI4077639T3 (fi) 2024-08-22
JP2023506413A (ja) 2023-02-16
US20260061057A1 (en) 2026-03-05
US12491248B2 (en) 2025-12-09

Similar Documents

Publication Publication Date Title
EP3758719A4 (en) METHODS FOR IMPROVING THE DIFFERENTIATION OF STEM CELLS INTO BETA CELLS
IL272234A (en) High-throughput single-cell transcriptome libraries and methods of making and of using
IL287468A (en) Nucleic acid constructs and methods for their manufacture
IL268723A (en) Method and cell line for production of phytocannabinoids and phytocannabinoid analogues in yeast
PL3855561T3 (pl) Sposób wytwarzania ogniwa elektrycznego z masą zalewową
EP3775156A4 (en) AUTOMATED CELL BREWING
EP4073854A4 (en) Anode for lithium-ion battery and method of fabricating same
EP3863100A4 (en) METHOD OF MANUFACTURE OF A LITHIUM ION CELL AND LITHIUM ION CELL
IL258844A (en) Methods for culturing cells and kits and apparatus for same
KR102204140B9 (ko) 전고체 전지 및 이의 제조방법
PL3443609T3 (pl) Sposoby produkcyjne o dużej przepustowości do wytwarzania elektrochemicznych ogniw elementarnych oraz elektrochemiczne ogniwa elementarne wytwarzane przy ich zastosowaniu
PL4077639T3 (pl) Sposób wytwarzania komórek immunoregulatorowych w próbce pochodzącej z krwi
EP3633687C0 (en) ELECTROLYTE FOR ELECTROCHEMICAL DEVICE AND PREPARATION METHOD THEREOF
EP4167343C0 (en) METHOD FOR IMPROVING THE PERFORMANCE OF AN ELECTROCHEMICAL CELL
EP4022041A4 (en) NEF-CONTAINING T CELLS AND METHODS OF PRODUCTION THEREOF
IL304401A (en) Blastocyst-like cell aggregate and methods
EP4016568A4 (en) SEPARATOR FOR BATTERIES AND ITS PRODUCTION METHOD
PL3835415T3 (pl) Sposób wytwarzania komórki cd3-dodatniej
EP3591040A4 (en) METHOD OF PRODUCTION OF PANCREATIC PROGENITOR CELLS
EP3515862A4 (en) ELECTROCHEMICAL CELLS AND METHOD FOR THE PRODUCTION THEREOF
IL284893A (en) A method for screening of an in vitro display library within a cell
EP3950711A4 (en) CELL CONSTRUCT AND METHODS OF PRODUCTION
FR3053051B1 (fr) Cassette et automate de culture cellulaire
EP4084171A4 (en) SECONDARY BATTERY AND ITS MANUFACTURING METHOD
EP4054601A4 (en) MANUFACTURING PROCESSES FOR CELLULAR THERAPIES